Translational Barriers and AI‐Driven Challenges of Microfluidics‐Enabled Wearables and Implantable Systems in Personalized Medicine
Advanced Science · 2026
DOI: 10.1002/advs.77296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, 2026. Verfasst von Ke Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Biomedicine, City University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Precision Medicine, Wearable Electronic Devices, Microfluidics, Prostheses and Implants. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: City University of Hong Kong, Research Grants Council (RGC), Innovation and Technology Commission.
Abstract (Originalsprache)
Wearable and implantable microfluidic systems have progressed from laboratory prototypes toward translational clinical deployment, enabling continuous, minimally invasive sampling of dynamic biomarkers across sweat, saliva, tears, and interstitial fluid. However, existing reviews often address materials chemistry or device fabrication in isolation, obscuring the systemic path to clinical translation. This review establishes a cohesive, translation‐focused linear trajectory starting from foundational functional biomaterials and advanced fabrication techniques, transitioning into a performance benchmarking of diagnostics‐oriented systems and closed‐loop theranostic platforms. Through these vectors, we systematically evaluate how microfluidic transport, multiplexed molecular analytics, and autonomous therapeutic integration collectively drive the shift from passive tracking to adaptive intervention. Beyond physical hardware, we decode the integration of artificial intelligence (AI) across three precise pathways: sensor self‐calibration, multiplexed molecular decoding, and on‐device autonomous decision‐making. Finally, we critically examine the socio‐technical barriers to clinical translation, with a focus on how biofluid data heterogeneity and population baseline disparities propagate algorithmic bias. We propose that robust hardware interfaces, standardized validation benchmarks, and alignment with emerging regulatory frameworks are prerequisites for achieving equitable, responsible digital health protection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, College of Biomedicine, City University of Hong Kong, Hong Kong, China.
- Hong Kong Center for Cerebro-Cardiovascular Health Engineering (COCHE), Hong Kong, China.
- Institute of Digital Medicine, City University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Ke Huang, Ching Yin Fong, Bee Luan Khoo
Förderung
- City University of Hong Kong
- Research Grants Council (RGC)
- Innovation and Technology Commission
Zitieren
APA
Huang, K., Fong, C. Y., Huang, X., & Khoo, B. L. (2026). Translational Barriers and AI‐Driven Challenges of Microfluidics‐Enabled Wearables and Implantable Systems in Personalized Medicine. Advanced Science. https://doi.org/10.1002/advs.77296
Vancouver
Huang K, Fong CY, Huang X, Khoo BL. Translational Barriers and AI‐Driven Challenges of Microfluidics‐Enabled Wearables and Implantable Systems in Personalized Medicine. Advanced Science. 2026. doi:10.1002/advs.77296
BibTeX
@article{Huang2026,
author = {Huang, Ke and Fong, Ching Yin and Huang, Xin and Khoo, Bee Luan},
title = {Translational Barriers and AI‐Driven Challenges of Microfluidics‐Enabled Wearables and Implantable Systems in Personalized Medicine},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.77296}
}
EUVIMED